Posted in entertainment, media & arts
Film has always had a special place in my heart. It’s helped me through so many stages in my life.
I’ve felt so unmotivated these past few years and decided to work on something that would inspire me.
So, if you feel unmotivated right now or just seem like you’re stuck, I hope this video helps you in some way.
Thanks for watching!
Music: https://audiojungle.net/item/to-the-stars/22166613?s_rank=36
For business inquiries: [email protected]
https://paper.li/e-1437691924#/
Stefan Lorenz Sorgner, Ph.D. is a German metahumanist philosopher, Nietzsche scholar, philosopher of music, and an authority in the field of ethics of emerging technologies.
Stefan teaches philosophy at John Cabot University in Rome and is director and cofounder of the Beyond Humanism Network, Fellow at the Institute for Ethics and Emerging Technologies (IEET), Research Fellow at the Ewha Institute for the Humanities at Ewha Womans University in Seoul, and Visiting Fellow at the Ethics Centre of the Friedrich-Schiller-University in Jena, where he was also Visiting Professor during the Summer of 2016. He is also Editor-in-Chief of the Journal of Posthuman Studies.
In recent years, he taught at the Universities of Jena (Germany), Erfurt (Germany), Klagenfurt (Austria), Ewha Womans University in Seoul (South Korea), and Erlangen-Nürnberg (Germany). His main fields of research are Nietzsche, the philosophy of music, bioethics and metahumanism, posthumanism, and transhumanism.
For over a century science fiction filmmaking has presented us with depictions of our future cities. Some have been bright, shiny and positive, while others have been dark, dirty and rough. As we look forward to a 21st century filled with massive mega-cities, and extraordinary technological innovation, we must ask how are our science fiction visions influencing the cities we build, and what can we learn from some of these prescient fictional texts?
The famous psychologist Timothy Leary once referred to himself as a “surfer,” envisioning a future where, “[t]o study biology, you can press a button and make yourself part of the human body. You can become a white blood cell and learn about the circulatory system by traveling through an artery. You can call up the Prado Museum in Madrid and study Goya’s paintings.”
When I think about the future, I envision mass technological disruptions across the entire landscape. Artificial intelligence (AI) being embedded into the very fabric of our architecture and institutions, 3D printing transforming our socio-economic system from scarcity to abundance, and virtual reality/augmented reality (VR/AR) unleashing infinite potential in shaping our perceptions of reality.
One could argue that we’ve already been experimenting with VR/AR via the use of psychedelic drugs, like psilopsybin, DMT, etc. But for many, the perception of these drugs tend to carry an unfortnate negative connotation. When people think of someone doing shrooms, a lot of them think of a person going mad in the middle of the woods. When people think of someone doing LSD, a lot of them think of a person believing they’re Peter Pan as they hoist themselves off the top of a skyscraper.
An interview with Dr. Vadim Gladyshev, Harvard University.
We have recently had occasion to have a chat with Dr. Vadim Gladyshev, Professor of Medicine and Director of Redox Medicine at Brigham and Women’s Hospital, Harvard Medical School, in Boston, Massachusetts. He is an expert in aging and redox biology and is known for his characterization of the human selenoproteome. His research laboratory focuses on comparative genomics, selenoproteins, redox biology, and, naturally, aging and lifespan control.
Dr. Gladyshev graduated from Moscow State University, in Moscow, Russia; his postdoctoral studies in the 1990s took place at the National Heart, Lung, and Blood Institute, and the National Cancer Institute, in Bethesda, Maryland. Even when he was young, he was very much interested in chemistry and experimental science: he twice won the regional Olympiad in chemistry and graduated from high school with a gold medal. He also graduated with the highest honors from Moscow State University. This enviable track record is even more impressive considering that Dr. Gladyshev completed music school and high school at the same time and became a chess player equivalent to national master during his college years.
You’ll have a chance to meet Dr. Gladyshev at our upcoming New York City conference, Ending Age-Related Diseases, on July 12; if you can’t attend, you can at least enjoy our interview with Dr. Gladyshev below.
System-sounds.com converts the orbits of Jupiter moons Io, Europa, Ganymede and Calisto into a mind-bending visual and audio experience.
In the heart of San Francisco’s Mission Bay neighborhood, which not long ago was dirt lots and warehouses, Emily Leproust is cooking up what she — and $209 million worth of investor cash — believes is the future of DNA production.
Leproust is CEO of Twist Bioscience, a 5-year-old biotech company striving to make the production of synthetic DNA — which is used in fragrances, genetically modified foods and pharmaceutical drugs — cheaper, faster and smaller.
The same lab-manufactured DNA, Leproust hopes, could also transform the way data, from music to medical records, is stored.
Not surprising and yet fascinating to actually see — “The researchers found that music activates the brain, causing whole regions to communicate. By listening to the personal soundtrack, the visual network, the salience network, the executive network and the cerebellar and corticocerebellar network pairs all showed significantly higher functional connectivity.”
“Ever get chills listening to a particularly moving piece of music? You can thank the salience network of the brain for that emotional joint. Surprisingly, this region also remains an island of remembrance that is spared from the ravages of Alzheimer’s disease. Researchers at the University of Utah Health are looking to this region of the brain to develop music-based treatments to help alleviate anxiety in patients with dementia. Their research will appear in the April online issue of The Journal of Prevention of Alzheimer’s Disease…
